Search research articles
Contact Us
Filters
Showing results (151-160 of 198) with videos related to
Page
of 20
Sort By:
Haematologica
|
August 27, 1998
Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis
G Martinelli, N Testoni, V Montefusco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 2006
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies
H T Mouridsen, S W Langer, J Buter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
U Tirelli, D Errante, M Van Glabbeke, et al.
Leukemia & Lymphoma
|
May 9, 2001
Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's Lymphoma?
C Dazzi, A Cariello, G Rosti, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 25, 2019
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
M Mancini, S De Santis, C Monaldi, et al.
Bone Marrow Transplantation
|
July 25, 1998
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
M Cavo, G Bandini, M Benni, et al.
Leukemia & Lymphoma
|
September 7, 2000
Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response
G Martinelli, V Montefusco, M Amabile, et al.
Tumori
|
April 4, 1998
The use of granulocyte colony-stimulating factors following peripheral blood progenitor cell rescue after high-dose chemotherapy for advanced breast cancer: a prospective study
C Dazzi, L Albertazzi, G Rosti, et al.
Bone Marrow Transplantation
|
April 4, 2000
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy
G Martinelli, N Testoni, M Amabile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2006
High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults
P Pedrazzoli, J A Ledermann, J-P Lotz, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 198) with videos related to
Sort By:
Page
of 20
Haematologica
|
August 27, 1998
Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis
G Martinelli, N Testoni, V Montefusco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 2006
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies
H T Mouridsen, S W Langer, J Buter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
U Tirelli, D Errante, M Van Glabbeke, et al.
Leukemia & Lymphoma
|
May 9, 2001
Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's Lymphoma?
C Dazzi, A Cariello, G Rosti, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 25, 2019
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
M Mancini, S De Santis, C Monaldi, et al.
Bone Marrow Transplantation
|
July 25, 1998
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
M Cavo, G Bandini, M Benni, et al.
Leukemia & Lymphoma
|
September 7, 2000
Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response
G Martinelli, V Montefusco, M Amabile, et al.
Tumori
|
April 4, 1998
The use of granulocyte colony-stimulating factors following peripheral blood progenitor cell rescue after high-dose chemotherapy for advanced breast cancer: a prospective study
C Dazzi, L Albertazzi, G Rosti, et al.
Bone Marrow Transplantation
|
April 4, 2000
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy
G Martinelli, N Testoni, M Amabile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2006
High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults
P Pedrazzoli, J A Ledermann, J-P Lotz, et al.
Page
of 20